Jim Simons acquired 1.23 Million Jazz Pharmaceuticals plc shares worth $134 Million. That's 0.20% of their equity portfolio (97th largest holding). The investor owns 1.88% of the outstanding Jazz Pharmaceuticals plc stock. The first Jazz Pharmaceuticals plc trade was made in Q2 2013. Since then Jim Simons bought shares nineteen more times and sold shares on twenty occasions. The investor's estimated purchase price is $165 Million, resulting in a loss of 19%.